Find out more about Eugene Maraskovsky's experience
Eugene Maraskovsky's highlights
Eugene Maraskovsky's selected work
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenic..
A potential association between IL-3 and type I and III interferons in systemic lupus eryt..
Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of p..
The Role of II Human Leukocyte Antigens (cII-HLAs) in Determining the Immunogenic Potentia..
Displaying the 33 most recent scholarly works by Eugene Maraskovsky.
Therapeutic ISCOMATRIX (TM) adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer
Adele M Barr, Anabel Silva, Sandro Prato, Gabrielle T Belz, Eugene Maraskovsky, Adriana Baz Morelli
Journal article | 2020 | Cancer Immunology, Immunotherapy
Cancer vaccine development has proven challenging with the exception of some virally induced cancers for which prophylactic vaccin..
Butyrophilin 2A1 is essential for phosphoantigen reactivity by gamma delta T cells
Marc Rigau, Simone Ostrouska, Thomas S Fulford, Darryl N Johnson, Katherine Woods, Zheng Ruan, Hamish EG McWilliam, Christopher Hudson, Candani Tutuka, Adam K Wheatley, Stephen J Kent, Jose A Villadangos, Bhupinder Pal, Christian Kurts, Jason Simmonds, Matthias Pelzing, Andrew D Nash, Andrew Hammet, Anne M Verhagen, Gino Vairo, et al.
Journal article | 2020 | Science
Gamma delta (γδ) T cells are essential to protective immunity. In humans, most γδ T cells express Vγ9Vδ2+ T cell receptors (TCRs) ..
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
Wojciech Jankowski, Yara Park, Joseph McGill, Eugene Maraskovsky, Marco Hofmann, Vincent P Diego, Bernadette W Luu, Tom E Howard, Roberta Kellerman, Nigel S Key, Zuben E Sauna
Journal article | 2019 | Blood Advances
A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus
Shereen Oon, Katherine Monaghan, Milica Ng, Alberta Hoi, Eric Morand, Gino Vairo, Eugene Maraskovsky, Andrew D Nash, Ian P Wicks, Nicholas J Wilson
Journal article | 2019 | Clinical & Translational Immunology
Objectives: Plasmacytoid dendritic cells (pDCs), through the production of type 1 interferons (IFNs) and other cytokines, are majo..
Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus
William A Figgett, Katherine Monaghan, Milica Ng, Monther Alhamdoosh, Eugene Maraskovsky, Nicholas J Wilson, Alberta Y Hoi, Eric F Morand, Fabienne Mackay
Journal article | 2019 | Clinical & Translational Immunology
The Role of II Human Leukocyte Antigens (cII-HLAs) in Determining the Immunogenic Potential of Therapeutic Factor VIII Proteins in Hemophilia Patients: The "Gate Keeper" Hypothesis
Vincent P Diego, Bernadette W Luu, Marco Hofmann, Marcio A Almeida, Jose Antonio G Hernandez, Juan Peralta, Joanne Curran, Jerry S Powell, Raja Rajalingam, Long V Dinh, Sarah Williams-Blangero, Miguel A Escobar, Eugene Maraskovsky, John Blangero, Tom E Howard
Conference Proceedings | 2018 | Blood
A Novel Cellular Pathway of Antigen Presentation and CD4 T Cell Activation in vivo
Hannah E Scales, Gavin R Meehan, Alan J Hayes, Robert A Benson, Emma Watson, Anne Walters, Michio Tomura, Eugene Maraskovsky, Paul Garside, Adriana Baz Morelli, James M Brewer
Journal article | 2018 | Frontiers in Immunology
ANALYSIS OF HLACII PEPTIDOMES PRESENTED BY DENDRITIC CELLS (DCS) FROM HEALTHY DONORS AND HEMOPHILIA-A (HA) PATIENTS WITH OR WITHOUT FACTOR VIII (FVIII) INHIBITORS AFTER EX VIVO ADMINISTRATION OF DIFFERENT THERAPEUTIC FVIII PROTEINS (TFVIIIS)
Tom E Howard, Vincent P Diego, Marco Hofmann, Marcio Almeida, Bernadette W Luu, Long V Dinh, Raja Rajalingam, Miguel Escobar, Joanne Curran, Sarah Williams-Blangero, Jerry Powell, John Blangero, Eugene Maraskovsky, Nigel S Key, Zuben E Sauna
Conference Proceedings | 2018 | Human Immunology
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant.
Ian D Davis, Juliet Quirk, Leone Morris, Lauren Seddon, Tsin Yee Tai, Genevieve Whitty, Tina Cavicchiolo, Lisa Ebert, Heather Jackson, Judy Browning, Duncan MacGregor, Frederick Wittke, Gregor Winkels, Regina Alex, Lena Miloradovic, Eugene Maraskovsky, Weisan Chen, Jonathan Cebon
Journal article | 2017 | Immunotherapy
AIM: Pilot clinical trial of NY-ESO-1 (ESO) protein in ISCOMATRIX™ adjuvant pulsed onto peripheral blood dendritic cells (PBDC), t..
A cytotoxic anti-IL-3R alpha antibody targets key cells and cytokines implicated in systemic lupus erythematosus
Shereen Oon, Huy Huynh, Tsin Yee Tai, Milica Ng, Katherine Monaghan, Mark Biondo, Gino Vairo, Eugene Maraskovsky, Andrew D Nash, Ian P Wicks, Nicholas J Wilson
Journal article | 2016 | JCI Insight
Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils
Ian K Campbell, Sylvia Miescher, Donald R Branch, Patrick J Mott, Alan H Lazarus, Dongji Han, Eugene Maraskovsky, Adrian W Zuercher, Anton Neschadim, Danila Leontyev, Brent S McKenzie, Fabian Kaesermann
Journal article | 2014 | Journal of Immunology
Regulatory T-Cell - Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
Theo Nicholaou, Lisa M Ebert, Ian D Davis, Grant A McArthur, Heather Jackson, Nektaria Dimopoulos, Bee Tan, Eugene Maraskovsky, Lena Miloradovic, Wendie Hopkins, Linda Pan, Ralph Venhaus, Eric W Hoffman, Weisan Chen, Jonathan Cebon
Journal article | 2009 | Clinical Cancer Research
Priming of CD4( ) and CD8( ) T cell responses using a HCV core ISCOMATRIX (TM) vaccine A phase I study in healthy volunteers
Debbie Drane, Eugene Maraskovsky, Rebecca Gibson, Sue Mitchell, Megan Barnden, Alan Moskwa, David Shaw, Barbara Gervase, Stephen Coates, Michael Houghton, Russel Basser
Journal article | 2009 | Human Vaccines
ISCOMATRIX Adjuvant Induces Efficient Cross-Presentation of Tumor Antigen by Dendritic Cells via Rapid Cytosolic Antigen Delivery and Processing via Tripeptidyl Peptidase II
Max Schnurr, Martin Orban, Neil C Robson, Amanda Shin, Hal Braley, Denise Airey, Jonathan Cebon, Eugene Maraskovsky, Stefan Endres
Journal article | 2009 | Journal of Immunology
Characterization of antigen-specific CD8 T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination.
Qiyuan Chen, Heather Jackson, Mark Shackleton, Phillip Parente, Wendie Hopkins, Sue Sturrock, Duncan MacGregor, Eugene Maraskovsky, Tsin Yee Tai, Nektaria Dimopoulos, Kelly-Anne Masterman, Tina Luke, Ian D Davis, Weisan Chen, Jonathan Cebon
Journal article | 2005 | Cancer Immunity
Immune responses to cancer vaccines are commonly tested by measuring cutaneous reactions to intradermal (i.d.) antigen. When well-..
Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development
M O'Keeffe, TC Brodnicki, B Fancke, D Vremec, G Morahan, E Maraskovsky, R Steptoe, LC Harrison, K Shortman
Journal article | 2005 | International Immunology
Recombinant NY-ESO-1 cancer antigen: Production and purification under cGMP conditions
R Murphy, S Green, G Ritter, L Cohen, D Ryan, W Woods, M Rubira, J Cebon, ID Davis, A Sjolander, A Kypridis, H Kalnins, M McNamara, MB Moloney, J Ackland, G Cartwright, J Rood, G Dumsday, K Healey, D Maher, et al.
Journal article | 2005 | Preparative Biochemistry & Biotechnology
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.
Mark Shackleton, Ian D Davis, Wendie Hopkins, Heather Jackson, Nektaria Dimopoulos, Tsin Tai, Qiyuan Chen, Phillip Parente, Michael Jefford, Kelly-Anne Masterman, Dania Caron, Weisan Chen, Eugene Maraskovsky, Jonathan Cebon
Journal article | 2004 | Cancer Immunity
Dendritic cells (DCs) show promise as adjuvants in anticancer immunotherapeutic strategies. Flt3 ligand (FL) is a hematopoietic gr..
Immunodominant CD4( ) responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
QY Chen, H Jackson, P Parente, T Luke, M Rizkalla, TY Tai, HC Zhu, NA Mifsud, N Dimopoulos, KA Masterman, W Hopkins, H Goldie, E Maraskovsky, S Green, L Miloradovic, J McCluskey, LJ Old, ID Davis, J Cebon, WS Chen
Journal article | 2004 | Proceedings of the National Academy of Sciences of the United States of America
Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: Intracellular loading and kinetics of presentation
T Luft, M Rizkalla, TY Tai, QY Chen, RI MacFarlan, ID Davis, E Maraskovsky, J Cebon
Journal article | 2001 | Journal of Immunology
Medicine - Austin Health
Doctor of Philosophy
Institution not known